Plasma adiponectin is a potential biomarker for organ involvement in male Fabry disease patients.

doi:10.1016/j.bcmd.2019.102379

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Plasma adiponectin is a potential biomarker for organ involvement in male Fabry disease patients.

Blood cells, molecules & diseases - 1 Feb 2020

Hovakimyan Marina, Talabattula Venkata Ajay Narendra, Cozma Claudia, Beetz Christian, Rolfs Arndt, Elstein Deborah

Abstract excerpt

Fabry disease is an X-linked lysosomal storage disorder caused by pathogenic variants in GLA. It manifests in hemizygous males and in many heterozygous females. Cardiovascular and renal involvement are frequent. Adiponectin is a circulating hormone that has been linked to numerous disease conditions including heart and kidney failure. In the present pilot study, we investigated plasma adiponectin levels in a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adiponectin
Share to Aged, 80 and over
Share to Biomarkers
Share to Fabry Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kidney

Share to Organ Specificity

Share to Sex Factors

Share to Symptom Assessment

Source

Open in PubMed

Identifiers

PMID: 31715450
DOI: 10.1016/j.bcmd.2019.102379

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.